XML 30 R18.htm IDEA: XBRL DOCUMENT
v3.25.2

Financial Instruments | 6 Months Ended
--- | ---
Jun. 30, 2025
Financial Instruments [Abstract] |
Financial Instruments | 9. Financial Instruments A. Debt Credit Facilities In December 2022, we entered into an amended and restated revolving credit agreement with a syndicate of banks providing for a multi-year $1.0 billion senior unsecured revolving credit facility (the credit facility), which expires in December 2027. Subject to certain conditions, we have the right to increase the credit facility to up to $1.5 billion. The credit facility contains a financial covenant requiring us to not exceed a maximum total leverage ratio (the ratio of consolidated net debt as of the end of the period to consolidated Earnings Before Interest, Income Taxes, Depreciation and Amortization (EBITDA) for such period) of 3.50:1. Upon entering into a material acquisition, the maximum total leverage ratio increases to 4.00:1, and extends until the fourth full consecutive fiscal quarter ended immediately following the consummation of a material acquisition. In addition, the credit facility contains other customary covenants. We were in compliance with all financial covenants as of June 30, 2025 and December 31, 2024. There were no amounts drawn under the credit facility as of June 30, 2025 or December 31, 2024. We have additional lines of credit and other credit arrangements with a group of banks and other financial intermediaries for general corporate purposes. We maintain cash and cash equivalent balances in excess of our outstanding short-term borrowings. As of June 30, 2025, we had access to $53 million of lines of credit which expire at various times and are generally renewed annually. There were no borrowings outstanding related to these facilities as of June 30, 2025 and December 31, 2024. Commercial Paper Program In February 2013, we entered into a commercial paper program with a capacity of up to $1.0 billion. As of June 30, 2025 and December 31, 2024, there was no commercial paper outstanding under this program. Senior Notes and Other Long-Term Debt Our senior notes are governed by an indenture and supplemental indentures (collectively, the indenture) between us and Deutsche Bank Trust Company Americas, as trustee. The indenture contains certain covenants, including limitations on our and certain of our subsidiaries’ ability to incur liens or engage in sale-leaseback transactions. The indenture also contains restrictions on our ability to consolidate, merge or sell substantially all of our assets. In addition, the indenture contains other customary terms, including certain events of default, upon the occurrence of which the senior notes may be declared immediately due and payable. Pursuant to the indenture, we are able to redeem the senior notes of any series, in whole or in part, at any time by paying a “make whole” premium, plus accrued and unpaid interest to, but excluding, the date of redemption. Upon the occurrence of a change of control of us and a downgrade of the senior notes below an investment grade rating by each of Moody’s Investors Service, Inc. and Standard & Poor’s Ratings Services, we are, in certain circumstances, required to make an offer to repurchase all of the outstanding senior notes at a price equal to 101% of the aggregate principal amount of the senior notes together with accrued and unpaid interest to, but excluding, the date of repurchase. The components of our long-term debt are as follows:
|  | June 30, |  | December 31,
(MILLIONS OF DOLLARS) |  | 2025 |  | 2024
4.500% 2015 senior notes due 2025 |  | $ | 750 |  |  | $ | 750 |
5.400% 2022 senior notes due 2025 |  | 600 |  |  | 600 |
3.000% 2017 senior notes due 2027 |  | 750 |  |  | 750 |
3.900% 2018 senior notes due 2028 |  | 500 |  |  | 500 |
2.000% 2020 senior notes due 2030 |  | 750 |  |  | 750 |
5.600% 2022 senior notes due 2032 |  | 750 |  |  | 750 |
4.700% 2013 senior notes due 2043 |  | 1,150 |  |  | 1,150 |
3.950% 2017 senior notes due 2047 |  | 500 |  |  | 500 |
4.450% 2018 senior notes due 2048 |  | 400 |  |  | 400 |
3.000% 2020 senior notes due 2050 |  | 500 |  |  | 500 |
|  | 6,650 |  |  | 6,650 |
Unamortized debt discount / debt issuance costs |  | (51) |  |  | (54) |
Less current portion of long-term debt |  | 1,350 |  |  | 1,350 |
Cumulative fair value adjustment for interest rate swap contracts |  | (18) |  |  | (26) |
Long-term debt, net of discount and issuance costs |  | $ | 5,231 |  |  | $ | 5,220 |
The fair value of our long-term debt was $6,229 million and $6,097 million as of June 30, 2025 and December 31, 2024, respectively, and has been determined using a third-party model that uses significant inputs derived from, or corroborated by, observable market data, including benchmark security prices and Zoetis’ credit spreads (Level 2 inputs). The following table provides the principal amount of debt outstanding, as of June 30, 2025, by scheduled maturity date:
|  |  |  |  |  |  |  |  |  |  |  | After |  |
(MILLIONS OF DOLLARS) |  | 2025 |  | 2026 |  | 2027 |  | 2028 |  | 2029 |  | 2029 |  | Total
Maturities |  | $ | 1,350 |  |  | $ | — |  |  | $ | 750 |  |  | $ | 500 |  |  | $ | — |  |  | $ | 4,050 |  |  | $ | 6,650 |
Interest Expense Interest expense, net of capitalized interest, was $53 million and $107 million for the three and six months ended June 30, 2025, respectively, and $59 million and $117 million for the three and six months ended June 30, 2024, respectively. Capitalized interest expense was $11 million and $22 million for the three and six months ended June 30, 2025, respectively, and $9 million and $17 million for the three and six months ended June 30, 2024, respectively. B. Derivative Financial Instruments Foreign Exchange Risk A significant portion of our revenue, earnings and net investment in foreign affiliates is exposed to changes in foreign exchange rates. We seek to manage our foreign exchange risk, in part, through operational means, including managing same-currency revenue in relation to same-currency costs and same-currency assets in relation to same-currency liabilities. Depending on market conditions, foreign exchange risk is also managed through the use of various derivative financial instruments. These derivative financial instruments serve to manage the exposure of our net investment in certain foreign operations to changes in foreign exchange rates and protect net income against the impact of translation into U.S. dollars of certain foreign exchange-denominated transactions. All derivative financial instruments used to manage foreign currency risk are measured at fair value and are reported as assets or liabilities on the Condensed Consolidated Balance Sheets. The derivative financial instruments primarily offset exposures in the Australian dollar, British pound, Canadian dollar, Chinese renminbi, euro and Norwegian krone. Changes in fair value are reported in earnings or in Accumulated other comprehensive loss, depending on the nature and purpose of the financial instrument, as follows: •For foreign currency forward-exchange contracts not designated as hedging instruments, we recognize the gains and losses that are used to offset the same foreign currency assets or liabilities immediately into earnings along with the earnings impact of the items they generally offset. These contracts essentially take the opposite currency position of that reflected in the month-end balance sheet to counterbalance the effect of any currency movement. The vast majority of the foreign currency forward-exchange contracts mature within 60 days and all mature within three years. •For foreign exchange derivative instruments that are designated as hedging instruments against our net investment in foreign operations, changes in the fair value are recorded as a component of cumulative translation adjustment within Accumulated other comprehensive loss and reclassified into earnings when the foreign investment is sold or substantially liquidated. These instruments include cross-currency interest rate swaps and foreign currency forward-exchange contracts. Gains and losses excluded from the assessment of hedge effectiveness are recognized in earnings (Interest expense, net of capitalized interest). The cash flows from these contracts are reflected within the investing section of our Condensed Consolidated Statements of Cash Flows. These contracts have varying maturities of up to three years. Interest Rate Risk The company may use interest rate swap contracts on certain investing and borrowing transactions to manage its net exposure to interest rates and to reduce its overall cost of borrowing. •In anticipation of issuing fixed-rate debt, we may use forward-starting interest rate swaps that are designated as cash flow hedges to hedge against changes in interest rates that could impact expected future issuances of debt. Unrealized gains or losses on the forward-starting interest rate swaps are reported in Accumulated other comprehensive loss and are recognized in earnings over the life of the future fixed rate notes. When the company discontinues hedge accounting because it is no longer probable that an anticipated transaction will occur within the originally expected period of execution, or within an additional two-month period thereafter, changes to fair value accumulated in other comprehensive income are recognized immediately in earnings. •During the period from 2019 to 2022, we entered into forward-starting interest rate swaps with an aggregate notional value of $650 million. We designated these swaps as cash flow hedges against interest rate exposure related principally to the issuance of fixed-rate debt to refinance our 3.250% 2013 senior notes due 2023. Upon issuance of our 2022 senior notes, we terminated these contracts and received $114 million in cash from the counterparties for settlement. The settlement amount, which represented the fair value of the contracts at the time of termination, was recorded in Accumulated other comprehensive loss, and will be amortized into income (offset to Interest expense, net of capitalized interest) over the life of the 5.600% 2022 senior notes due 2032. •As of June 30, 2025, we had outstanding forward-starting interest rate swaps, having an effective date and mandatory termination date in March 2026, to hedge against interest rate exposure related principally to the anticipated future issuance of fixed-rate debt to be used primarily to refinance our 4.500% 2015 senior notes due 2025. •We may use fixed-to-floating interest rate swaps that are designated as fair value hedges to hedge against changes in the fair value of certain fixed-rate debt attributable to changes in the benchmark of the Secured Overnight Financing Rate (SOFR). These derivative instruments effectively convert a portion of the company’s long-term debt from fixed-rate to floating-rate debt based on the daily SOFR rate plus a spread. Gains or losses on the fixed-to-floating interest rate swaps due to changes in SOFR are recorded in Interest expense, net of capitalized interest. Changes in the fair value of the fixed-to-floating interest rate swaps are offset by changes in the fair value of the underlying fixed-rate debt. As of June 30, 2025, we had outstanding fixed-to-floating interest rate swaps that correspond to a portion of the 3.900% 2018 senior notes due 2028 and the 2.000% 2020 senior notes due 2030. The amounts recorded during the three and six months ended June 30, 2025 for changes in the fair value of these hedges are not material to our condensed consolidated financial statements. Outstanding Positions The aggregate notional amount of derivative instruments are as follows:
|  | Notional
|  | June 30, |  | December 31,
(MILLIONS) |  | 2025 |  | 2024
Derivatives not Designated as Hedging Instruments: |  |  |  |
Foreign currency forward-exchange contracts |  | $ | 2,123 |  |  | $ | 2,070 |
Derivatives Designated as Hedging Instruments: |  |  |  |
Foreign exchange derivative instruments (in foreign currency): |  |  |  |
Euro |  | 925 |  |  | 800 |
Danish krone |  | 400 |  |  | 475 |
Swiss franc |  | 25 |  |  | 25 |
Forward-starting interest rate swaps |  | $ | 600 |  |  | $ | 300 |
Fixed-to-floating interest rate swap contracts |  | $ | 250 |  |  | $ | 250 |
Fair Value of Derivative Instruments The classification and fair values of derivative instruments are as follows:
|  | Fair Value of Derivatives
|  | June 30, |  | December 31,
(MILLIONS OF DOLLARS) | Balance Sheet Location | 2025 |  | 2024
Derivatives Not Designated as Hedging Instruments: |  |  |  |
Foreign currency forward-exchange contracts | Other current assets | $ | 6 |  |  | $ | 18 |
Foreign currency forward-exchange contracts | Other current liabilities | (11) |  |  | (6) |
Total derivatives not designated as hedging instruments |  | $ | (5) |  |  | $ | 12 |
Derivatives Designated as Hedging Instruments: |  |  |  |
Forward-starting interest rate swap contracts | Other current assets | $ | 19 |  |  | $ | — |
Forward-starting interest rate swap contracts | Other noncurrent assets | — |  |  | 26 |
Forward-starting interest rate swap contracts | Other current liabilities | (10) |  |  | — |
Foreign exchange derivative instruments | Other current assets | 7 |  |  | 55 |
Foreign exchange derivative instruments | Other noncurrent assets | — |  |  | 4 |
Foreign exchange derivative instruments | Other current liabilities | (31) |  |  | — |
Foreign exchange derivative instruments | Other noncurrent liabilities | (58) |  |  | — |
Fixed-to-floating interest rate swap contracts | Other noncurrent liabilities | (18) |  |  | (26) |
Total derivatives designated as hedging instruments |  | (91) |  |  | 59 |
Total derivatives |  | $ | (96) |  |  | $ | 71 |
The company’s derivative transactions are subject to master netting agreements that mitigate credit risk by permitting net settlement of transactions with the same counterparty. The company also has collateral security agreements with certain of its counterparties. Under these collateral security agreements each party is required to post cash collateral when the net fair value of derivative instruments covered by the collateral agreement exceeds contractually established thresholds. At June 30, 2025, there was $5 million of collateral received and $64 million of collateral posted related to derivative instruments recorded in Other current liabilities and Other current assets, respectively. At December 31, 2024, there was $51 million of collateral received and $20 million of collateral posted related to derivative instruments recorded in Other current liabilities and Other current assets, respectively. We use a market approach in valuing financial instruments on a recurring basis. Our derivative financial instruments are measured at fair value on a recurring basis using Level 2 inputs in the calculation of fair value. The amounts of net gains on derivative instruments not designated as hedging instruments, recorded in Other (income)/deductions—net, are as follows:
|  | Three Months Ended |  | Six Months Ended
|  | June 30, |  | June 30,
(MILLIONS OF DOLLARS) |  | 2025 |  | 2024 |  | 2025 |  | 2024
Foreign currency forward-exchange contracts |  | $ | 55 |  |  | $ | 2 |  |  | $ | 39 |  |  | $ | 1 |
These amounts were substantially offset in Other (income)/deductions—net by the effect of changing exchange rates on the underlying foreign currency exposures. The amounts of unrecognized net (losses)/gains on interest rate swap contracts, recorded, net of tax, in Accumulated other comprehensive loss, are as follows:
|  | Three Months Ended |  | Six Months Ended
|  | June 30, |  | June 30,
(MILLIONS OF DOLLARS) |  | 2025 |  | 2024 |  | 2025 |  | 2024
Forward-starting interest rate swap contracts |  | $ | (2) |  |  | $ | 1 |  |  | $ | (13) |  |  | $ | 3 |
Foreign exchange derivative instruments |  | $ | (74) |  |  | $ | 2 |  |  | $ | (107) |  |  | $ | 18 |
Gains on interest rate swap contracts, recognized within Interest expense, net of capitalized interest, are as follows:
|  | Three Months Ended |  | Six Months Ended
|  | June 30, |  | June 30,
(MILLIONS OF DOLLARS) |  | 2025 |  | 2024 |  | 2025 |  | 2024
Foreign exchange derivative instruments |  | $ | 5 |  |  | $ | 4 |  |  | $ | 10 |  |  | $ | 8 |
The net amount of deferred gains related to derivative instruments designated as cash flow hedges that is expected to be reclassified from Accumulated other comprehensive loss into earnings over the next 12 months is not material.

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/825/tableOfContent + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Financial Instruments [Abstract] + References No definition available. + Details
Name: | zts_FinancialInstrumentsAbstract
Namespace Prefix: | zts_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration